Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.
about
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.Live Imaging of Immune Responses in Experimental Models of Multiple SclerosisGenetics, pathogenesis and clinical interventions in type 1 diabetesOpinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetesImmunosuppressive networks in the tumour environment and their therapeutic relevanceInvestigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction.2011 Update: antigen-specific therapy in type 1 diabetesCombination therapy with an anti-IL-1β antibody and GAD65 DNA vaccine can reverse recent-onset diabetes in the RIP-GP mouse model.Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection.Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNgamma.Autoantigens plus interleukin-10 suppress diabetes autoimmunity.Expression level of a pancreatic neo-antigen in beta cells determines degree of diabetes pathogenesis.Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection.Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradientRegulatory T cells interfere with glutathione metabolism in dendritic cells and T cellsAnti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing TregsAntigen-specific immunotherapy for autoimmune disease: fighting fire with fire?Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells.Antigen-based immune modulation: DNA vectors and beyond.Vaccination to prevent type 1 diabetes.Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis.Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance.Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion.Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes.Type I regulatory T cells in autoimmunity and inflammatory diseases.Memory T cells in human tumor and chronic inflammatory microenvironments: sleeping beauties re-awakened by a cytokine kiss.Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies.Real-time imaging of the pancreas during development of diabetes.Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatmentAntigen exposure shapes the ratio between antigen-specific Tregs and conventional T cells in human peripheral blood.Persistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant.Animal models of human type 1 diabetes.Inducing immune tolerance: a focus on Type 1 diabetes mellitus.How do regulatory T cells work?Transcriptional regulation by STAT6.Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.
P2860
Q27469830-C86BBDE3-2F59-49A6-9B53-654C1E71F2D9Q28075478-84DA8223-6E64-46AF-87CA-FC1090032A01Q28281029-DA49356F-19E5-4A0E-9F58-EC3CA410377FQ29393228-4286E4E0-B1AD-4BAC-B73C-C4B4FFBD69E3Q29619244-1D7CF368-5573-49F9-9D56-F88DFA4DE7C5Q30500186-814AD1A7-FDEA-4089-A5D8-A23B631C2509Q33593629-B396A6DA-8156-410A-812B-00AE70C298E6Q33646749-0BAD1EE2-5694-48F5-B566-5C551F3E3191Q33930475-20962E4E-BC1D-4A72-8F93-9B6C4402AF99Q34023585-6DE31C94-FADB-461D-80D0-85BAA40D5D23Q34113929-D200E932-61F7-4D16-B2FF-6952D0371386Q34238702-ADD7BCE2-A218-4E3B-A8DF-795339CA2719Q34355286-B9BE233A-23AE-4832-862C-239B1356B68BQ34430207-A6BCF11E-D8AC-468F-854A-B70A8AE89698Q34438825-4D63D9C1-5D50-4B04-BC19-F678AD0BFF21Q34546789-FBE3A1B3-DD87-4E31-9C28-CD44F8933549Q34567725-A8CA4671-35A5-45AC-9355-702C2B435838Q34574858-AED9B813-1ECD-4819-A2EC-15CA7802064BQ35040861-68DBF16A-35F0-4184-9ACD-D2F16E6C37C3Q35195910-904D80A3-90BC-40CB-B31E-91621B542BDAQ35612665-44FF9F49-8509-471A-BF2A-B0CFD82E80FBQ35827715-06CD3FB0-B46B-4C9D-AD36-28EC663C0F82Q35839611-F79EF345-F7C4-491C-9371-DF6D1F2634D5Q36107928-0EC06105-E4C1-47F3-BBD0-E6E168446635Q36327362-56AC4AD2-1BAE-4E50-B064-92ECAFC02CE5Q36370315-A3F80A33-C0BB-4E86-ACB1-AFC6580971B7Q36399438-2B12B359-41C1-4605-AADA-B46E65585596Q36443071-210FA2C9-71BD-4210-A2E8-813E370DECC1Q36569011-3BBD624E-5AC8-43A6-A357-A9E2AABC8804Q36954734-49446526-52C4-441B-97F4-3A06873A7F33Q37023049-5D2FE23E-BFB8-4AE9-8CB2-47BEEBE6DD2DQ37084899-A8E47BFA-E6F4-4522-9417-A1B29E5010F6Q37263111-635417F1-CAB6-451E-858D-815B115DD39DQ37346860-485913FA-6DE0-4AF6-9454-DB1A70CD92AAQ37351448-11C7D7FE-6025-4666-B568-7ACEFCB52925Q37369887-FEF37BE1-7BD5-4903-A009-74F86F9DE71BQ37542678-23F726DF-7CB4-4240-86DE-0C6A75F30F7FQ37596517-58958B7C-296A-4F4C-B30A-E4406FE8A7DDQ37858466-335E914C-E100-4821-BCB6-734D02E409D2Q38063547-9ACE913F-7DEF-48BB-8847-72394E60CAFF
P2860
Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Autoreactive CD4+ T cells prot ...... using the IL-4/Stat6 pathway.
@en
type
label
Autoreactive CD4+ T cells prot ...... using the IL-4/Stat6 pathway.
@en
prefLabel
Autoreactive CD4+ T cells prot ...... using the IL-4/Stat6 pathway.
@en
P2093
P1433
P1476
Autoreactive CD4+ T cells prot ...... n using the IL-4/Stat6 pathway
@en
P2093
J Petersen
M G von Herrath
M J Grusby
T P Dyrberg
P304
P356
10.1016/S1074-7613(00)80121-1
P407
P50
P577
1999-10-01T00:00:00Z